Destrin Contributes to Lung Adenocarcinoma Progression by Activating Wnt/β-Catenin Signaling Pathway.

导出原文传递

翻译打印收藏纠错

第一作者： Hui-Juan,Zhang

第一单位： Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, P.R. China.

作者： Hui-Juan,Zhang ^[1] ; Wen-Jing,Chang ^[1] ; Cai-Yun,Jia ^[1] ; Ling,Qiao ^[1] ; Jing,Zhou ^[1] ; Qing,Chen ^[1] ; Xiao-Wei,Zheng ^[2] ; Jian-Hua,Zhang ^[3] ; Hong-Chao,Li ^[4] ; Zheng-Yan,Yang ^[1] ; Zhong-Hua,Liu ^[5] ; Guang-Chao,Liu ^[1] ; Shao-Ping,Ji ^[6] ; Feng,Lu ^[7]

作者单位： Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, P.R. China. ^[1] Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, P.R. China.;Department of Clinical Laboratory, Puyang Hospital of Traditional Chinese Medicine, Puyang, P.R. China. ^[2] Department of Clinical Laboratory, Puyang Hospital of Traditional Chinese Medicine, Puyang, P.R. China. ^[3] Department of Pathology, Puyang Oilfeld General Hospital, Puyang, P.R. China. ^[4] Laboratory for NanoMedical Photonics, School of Basic Medical Science, Henan University, Kaifeng, P.R. China. ^[5] Department of Biochemistry and Molecular Biology, Medical School, Henan University, Kaifeng, P.R. China. lufeng@henu.edu.cn shaopingji@henu.edu.cn. ^[6] Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, P.R. China. lufeng@henu.edu.cn shaopingji@henu.edu.cn. ^[7]